Bergonié Institute breast cancer database study
Part of Cancer, Skin clinical trials.
This study collects information from people who are receiving their first breast cancer treatment at the Bergonié Institute. It helps the institute better understand breast cancer care and outcomes over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have breast cancer
- You are 18 years old or older
- Your first breast cancer treatment is at the Bergonié Institute
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is a registry study that collects real-world information about breast cancer care at the start of treatment. It may help researchers better understand which treatments work best for different groups of people.
This study looks at people who are being screened and just diagnosed with breast cancer and haven’t started treatment yet. It may help researchers understand how to better manage care from the start of treatment.
This study builds a clinical and biological database for people newly diagnosed with certain cancers. It may help doctors better understand cancer patterns and improve future care, and it involves agreeing to extra blood samples.
This study checks how well a previous early breast cancer treatment works over the long term and monitors safety. It may help you and future patients by providing long-term results from the original trial.
This study collects and stores tissue and fluid samples from people with a breast lump or breast cancer so researchers can study cancer biology in the future. It may help future patients by allowing better lab tests and research on why breast cancer starts, grows, and comes back.
This study collects and stores biological samples (like tissue or blood) from people with early-stage breast cancer to help future research. It’s mainly for people with a specific type of early breast cancer called high-grade DCIS.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.